(Q33760899)

29 July 2017

1 reference

title

Photopheresis: clinical applications and mechanism of action (English)

1 reference

29 July 2017

A H Rook

1

1 reference

29 July 2017

K R Suchin

2

1 reference

29 July 2017

D M Kao

3

1 reference

29 July 2017

E K Yoo

4

1 reference

29 July 2017

W H Macey

5

1 reference

29 July 2017

B J DeNardo

6

1 reference

29 July 2017

P G Bromely

7

1 reference

29 July 2017

Y Geng

8

1 reference

29 July 2017

J M Junkins-Hopkins

9

1 reference

29 July 2017

S R Lessin

10

1 reference

29 July 2017

1 September 1999

1 reference

The journal of investigative dermatology. Symposium proceedings

29 July 2017

1 reference

29 July 2017

4

1 reference

29 July 2017

1

1 reference

29 July 2017

85-90

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jidsp.5640188

29 July 2017

0 references

cites work

Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Squamous cell carcinoma complicating chronic venous leg ulceration: a study of the histopathology, course and survival in 25 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Cytokines in psoriasis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

A role for TGFbeta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

The immunopathology of psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Association between psoriasis severity and transforming growth factor beta(1) and beta (2) in plasma and scales from psoriatic lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-beta1-dependent cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Smad6 inhibits signalling by the TGF-beta superfamily.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Identification and activation of latent transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Regulation of immune responses by TGF-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Roles of TGFbeta signaling in epidermal/appendage development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Conditional epidermal expression of TGFbeta 1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

The effect of TGF-beta1 on immune responses of naïve versus memory CD4+ Th1/Th2 T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Two major Smad pathways in TGF-beta superfamily signalling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

The skin cancer paradox of psoriasis: a matter of life and death decisions in the epidermis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Altered expression of transforming growth factor-beta 1 mRNA and protein in mouse skin carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Immunonutrition and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

In or out? The dynamics of Smad nucleocytoplasmic shuttling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

The two faces of transforming growth factor beta in carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Inhibitory smads and tgf-Beta signaling in glomerular cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Animal models of psoriasis - what can we learn from them?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

1 reference

7 January 2021

Transforming growth factor beta (TGF-?) in inflammation: A cause and a cure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Transforming growth factor beta: the good, the bad, and the ugly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

TGF-beta in the evolution and resolution of inflammatory and immune processes. Introduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Transforming growth factor type beta induces monocyte chemotaxis and growth factor production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JIDSP.5640188

7 January 2021

Identifiers

DOI

10.1038/SJ.JIDSP.5640188

1 reference

29 July 2017

1 reference